Opposite modulation of capsaicin-evoked substance P release by glutamate receptors

Neurochemistry International

Volumn 35, Issue 6, 1999, Pages 471-478

  Cuesta, Maria C ^a   Arcaya, Jose L ^a   Cano, Georgina ^a   Sanchez, Lorelay ^a   Maixner, William ^b   Suarez Roca, Herberto ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Capsaicin; Glutamate receptors; Primary afferents; Substance P; Trigeminal nucleus caudalis

Indexed keywords

2 (CARBOXYCYCLOPROPYL)GLYCINE; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; CAPSAICIN; DIZOCILPINE; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNOREACTIVITY; MALE; MODULATION; NERVE FIBER C; NEURALGIA; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINAL NUCLEUS;

AFFERENT PATHWAYS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZOATES; CAPSAICIN; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; KAINIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; NERVE FIBERS; NOCICEPTORS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE P; TRIGEMINAL NUCLEI;

EID: 0032821537     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00081-9     Document Type: Article

References (41)

1. Aanonsen L.M., Seybold V.S. Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autorradiography. Synapse. 4:1989;1-10.
2. Abdullah, L.H., 1985. A Radioimmunoassay for substance P: biochemical and pathological studies. PH.D. thesis, Queens University of Belfast, Northern Ireland, UK.
3. Ault B., Hildebrand L.M. L-glutamate activates peripheral nociceptors. Agents Actions. 39:1993;C142-C144.
4. Chen G., Chalozonitis A., Shen K., Crain S.M. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures. Brain Research. 462:1988;372-377.
5. Davies J., Watkins J.C. Actions of D- and L- forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Research. 235:1982;378-386.
6. DeBiasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of the spinal dorsal horn. Procedings of the National Academy of Science. 8513:1988;7820-7824.
7. Devillers J., Simonnet G. Modulation of neuropeptide FF release from rat spinal cord slices by glutamate: involvement of NMDA receptors. European Journal of Pharmacology. 271:1994;185-192.
8. Fisher K., Coderre T.J. Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists. Neuroreport. 7:1996;2743-2747.
9. Fisher K., Coderre T.J. Hyperalgesia and allodynia induced by intrathecal (RS)-dihydroxyphenylglycine in rats. Neuroreport. 20:1998;1169-1172.
10. Fundytus M.E., Fisher K., Dray A., Henry J.L., Coderre T.J. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats. Neuroreport. 9:1998;731-735.
11. Gamse R., Molnar A., Lembeck F. Substance P release from spinal cord slices by capsaicin. Life Science. 25:1979;629-636.
12. Hokfelt T., Kellerth J.O., Nillson G., Pernow B. Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Research. 100:1975;235-252.
13. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 24:1988;739-768.
14. Humpel C., Saria A. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P and neurokinin A-like immunoreactivity are different in the rat striatum and substantia nigra. Neuroscience Letters. 105:1989;159-163.
15. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 194:1962;495-496.
16. Ishida M., Saitoh T., Shimamoto K., Ohfune Y., Shinosaki H. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. British Journal of Pharmacology. 109:1993;1169-1177.
17. Koerner J.F., Cotman C.W. Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Research. 216:1981;192-198.
18. Kudo Y., Akita K., Ishida M., Shinozaki H. A significant increase in intracellular Ca2+ concentration induced by (2 S,3R,4 S)-2-(carboxycyclopropyl)glycine, a new NMDA agonist, in cultured rat hippocampal neurons. Brain Research. 567:1991;342-345.
19. Li H., Ohishi H., Kinoshita A., Shigemoto R., Nomura S., Mizumo N. Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat. Neuroscience Letters. 223:1993;153-156.
20. Liu H., Wang H., Sheng M., Jan L.Y., Jan N.Y., Basbaum A.I. Evidence for presynaptic N-methyl-D-asparte autoreceptors in the spinal cord dorsal horn. Proceedings of the National Academy of Science. 91:1994;8383-8387.
21. Liu H., Mantyh P.W., Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferents. Nature. 386:1997;721-724.
22. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Research. 576:1992;254-262.
23. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J., Frenk H. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Research. 605:1993;164-168.
24. Marvison J.C., Martinez V., Grady E.F., Bunnet N.W., Mayer E.A. Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. Journal of Neuroscience. 17:1997;8129-8136.
25. Massardier D., Hunt P.F. A direct non-opioid interaction of dynorphin (1-13) with N-methyl-D-aspartate (NMDA) receptor. European Journal of Pharmacology. 170:1989;125-126.
26. Minami T., Nishiara I., Uda R., Ito S., Hyodo M., Hayaishi O. Involvement of glutamate receptors in allodynia induced by prostagladins E2 and F2alfa injected into conscious mice. Pain. 57:1994;225-231.
27. Nagy J.I., Hunt S.P., Iversen L.L., Emson P.C. Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience. 6:1981;1923-1934.
28. Neugebauer V.T., Lucke T., Schaible H. Requirements of metabotropic glutamate receptors for the generation of inflammation-evoked hyperexcitability in rat spinal cord neurons. European Journal of Neuroscience. 6:1994;1179-1186.
29. Rane S.G., Dunlap K. Kinase C activator 1,2-oleoylacetylglycerol attenuates voltage-dependent calcium current in sensory neurons. Proceedings of the National Academy of Science (USA). 83:1986;184-188.
30. Ruzicka B.B., Jhamandas K.H. Excitatory amino acid action on the release on brain neurotransmitters and neuromodulators: biochemical studies. Progress in Neurobiology. 40:1993;223-247.
31. Salt T.E., Eaton S.A. Distinct presynaptic metabotropic receptors for L-AP4 and CCG-I on GABAergic terminals: pharmacological evidence using novel alfa-methyl derivative mGluR antagonists MAP4 and MCPG, in the rat thalamus in vivo. Neuroscience. 65:1995;5-13.
32. Shen K.F., Crain S.M. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid dependence without tolerance. Brain Research. 597:1992;74-83.
33. Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in the adult and developing rat. Journal of Comparative Neurology. 322:1992;121-135.
34. Starke K. Presynaptic receptors. Annual Review of Pharmacology and Toxicology. 21:1981;7-30.
35. Suarez-Roca H., Abdullah L., Zuniga J., Madison S., Maixner W. Multiphasic effect of morphine on the release of substance P from the rat trigeminal nucleus caudalis. Brain Research. 579:1992;187-194.
36. Ueda H., Miyamae T., Fukushima N., Watanabe S., Misu Y. Evidence for a metabostatic opioid kappa-receptor inhibiting pertussis toxin sensitive metabotropic glutamate receptor-currents in Xenopus oocytes. F.E.B.S. Letters. 375:1995;201-205.
37. Valerio A., Rizonelli P., Paterlini M., Moretto G., Knopfel T., Kuhn R., Memo M., Spano P. mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study. Neuroscience Research. 28:1997;49-57.
38. Vidnyanszky Z., Hamori J., Negyessy L., Ruegg D., Knofel T., Kuhn R., Gorcs T.J. Cellular and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord. Neuroreport. 30:1994;209-213.
39. Watkins J., Collingridge G. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends in Pharmacology Science. 15:1994;333-342.
40. Wright R.A., Schoepp D.D. Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. European Journal of Pharmacology. 297:1996;275-282.
41. Young M.R., Fleetwood-Walter S.M., Dickinson T., Blackburn-Munro G., Sparrow H., Birch P.J., Bountra C. Behavioral and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Research. 777:1997;161-169.